Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 05, 2019 09:35 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to Present Preclinical Data on AUT06NG at the SITC Annual Meeting

LONDON, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment...
August 02, 2019 09:06 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8

LONDON, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...
May 14, 2019 06:30 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress

LONDON, May 14, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...
April 08, 2019 16:40 ET | Source: Autolus Therapeutics plc

Autolus Announces Proposed Public Offering in the United States

LONDON, April 08, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...
April 01, 2019 13:05 ET | Source: Autolus Therapeutics plc

Initial Results from Autolus Therapeutics’ ALLCAR19 Phase 1/2 Trial in Adult Acute Lymphoblastic Leukemia Presented at the AACR Annual Meeting

Initial results from the trial show 88% molecular complete response at one month with well-tolerated safety profile Management to Hold Conference Call on April 2, 2019 at 8:00am ET / 1:00pm BST ...
March 29, 2019 16:03 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019

LONDON, March 29, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the...
February 06, 2014 17:44 ET | Source: Genentech

From Nurse to Patient

MISSION, KS--(Marketwired - Feb 6, 2014) - (Family Features) Despite her career as a scrub nurse for general cancer surgeries, a personal diagnosis of cancer still came as a surprise. "It...